Redox regulation of sirtuin-1 by S-glutathiolation

Antioxidants and Redox Signaling

Volumn 13, Issue 7, 2010, Pages 1023-1032

  Zee, Rebecca S ^a   Yoo, Chris B ^a   Pimentel, David R ^a   Perlman, David H ^a   Burgoyne, Joseph R ^a   Hou, Xiuyun ^a   McComb, Mark E ^a   Costello, Catherine E ^a   Cohen, Richard A ^a   Bachschmid, Markus M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CYSTEINE; DISULFIDE; GLUTATHIONE; GLUTATHIONE DERIVATIVE; RESVERATROL; S NITROSOGLUTHATHIONE; S NITROSOTHIOL; SEPHAROSE; SIRTUIN 1; SIRTUIN 1 DEACETYLASE; UNCLASSIFIED DRUG;

CHEMICAL MODIFICATION; DRUG INHIBITION; ENZYME ACTIVITY; GLUTATHIOLATION; HUMAN; IC 50; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NITROSATION; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION;

CELL LINE; CYSTEINE; DISULFIDES; GLUTATHIONE; HUMANS; NITROSO COMPOUNDS; OXIDATION-REDUCTION; PROTEINS; S-NITROSOGLUTATHIONE; SIRTUIN 1; STILBENES;

EID: 77955862787     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3251     Document Type: Review

References (30)

1. Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, and Sa-doshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res 95: 971-980, 2004.
2. Autiero I, Costantini S, and Colonna G. Human sirt-1: Molecular modeling and structure-function relationships of an unordered protein. PLoS ONE 4: e7350, 2008.
3. Chandra A, Srivastava S, Petrash JM, Bhatnagar A, and Srivastava SK. Modification of aldose reductase by S-nitrosoglutathione. Biochemistry 36: 15801-15809, 1997.
4. Csiszar A, Labinskyy N, Podlutsky A, Kaminski PM, Wolin MS, Zhang C, Mukhopadhyay P, Pacher P, Hu F, de CR, Ballabh P, and Ungvari Z. Vasoprotective effects of resver-atrol and SIRT1: Attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am J Physiol Heart Circ Physiol 294: H2721-H2735, 2008.
5. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, and Ungvari Z. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: Role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol 291: H1694-H1699, 2006.
6. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, Kashiwaya Y, Hoffman E, Veech RL, and Sartorelli V. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12: 51-62, 2003.
7. Giustarini D, Milzani A, Aldini G, Carini M, Rossi R, and le-Donne I. S-nitrosation versus S-glutathionylation of protein sulfhydryl groups by S-nitrosoglutathione. Antioxid Redox Signal 7: 930-939, 2005.
8. Hart TW. Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutathione. Tetrahedron Lett 26: 2013-2016, 1985.
9. Klatt P, Molina EP, and Lamas S. Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J Biol Chem 274: 15857-15864, 1999.
10. Klatt P, Pineda ME, Perez-Sala D, and Lamas S. Novel application of S-nitrosoglutathione-Sepharose to identify proteins that are potential targets for S-nitrosoglutathione-induced mixed-disulphide formation. Biochem J 349: 567-578, 2000.
11. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, and Kouzarides T. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21: 2383-2396, 2002.
12. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, and Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106: 1614-1617, 2002.
13. Lin SJ, Ford E, Haigis M, Liszt G, and Guarente L. Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev 18: 12-16, 2004.
14. Liu Z, Rudd MA, Freedman JE, and Loscalzo J. S-Transni-trosation reactions are involved in the metabolic fate and biological actions of nitric oxide. J Pharmacol Exp Ther 284: 526-534, 1998.
15. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, and Westphal CH. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-716, 2007.
16. Min J, Landry J, Sternglanz R, and Xu RM. Crystal structure of a SIR2 homolog-NAD complex. Cell 105: 269-279, 2001.
17. Mohr S, Hallak H, de BA, Lapetina EG, and Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyc-eraldehyde-3-phosphate dehydrogenase. J Biol Chem 274: 9427-9430, 1999.
18. Napper AD, Hixon J, McDonagh T, Keavey K, Pons JF, Barker J, Yau WT, Amouzegh P, Flegg A, Hamelin E, Thomas RJ, Kates M, Jones S, Navia MA, Saunders JO, DiStefano PS, Curtis R. Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. J Med Chem 48: 8045-8054, 2005.
19. Percival MD, Ouellet M, Campagnolo C, Claveau D, and Li C. Inhibition of cathepsin K by nitric oxide donors: Evidence for the formation of mixed disulfides and a sulfenic acid. Biochemistry 38: 13574-13583, 1999.
20. Potente M and Dimmeler S. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 7: 2117-2122, 2008.
21. Prozorovski T, Schulze-Topphoff U, Glumm R, Baumgart J, Schroter F, Ninnemann O, Siegert E, Bendix I, Brustle O, Nitsch R, Zipp F, and Aktas O. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol 10: 385-394, 2008.
22. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, and Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113-118, 2005.
23. Sasaki T, Maier B, Koclega KD, Chruszcz M, Gluba W, Stukenberg PT, Minor W, and Scrable H. Phosphorylation regulates SIRT1 function. PLoS ONE 3: e4020, 2008.
24. Schilling B, Yoo CB, Collins CJ, and Gibson BW. Determining cysteine oxidation status using differential alkylation. Int J Mass Spectrom 236: 117-127, 2004.
25. Shelton MD, Chock PB, and Mieyal JJ. Glutaredoxin: Role in reversible protein S-glutathionylation and regulation of re-dox signal transduction and protein translocation. Antioxid Redox Signal 7: 348-366, 2005.
26. Vaziri H, Dessain SK, Ng EE, Imai SI, Frye RA, Pandita TK, Guarente L, and Weinberg RA. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159, 2001.
27. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, and Forstermann U. Resveratrol, a polyphenolic phyto-alexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106: 1652-1658, 2002.
28. West MB, Hill BG, Xuan YT, and Bhatnagar A. Protein glutathiolation by nitric oxide: An intracellular mechanism regulating redox protein modification. FASEB J 20: 1715-1717, 2006.
29. Yang Y, Fu W, Chen J, Olashaw N, Zhang X, Nicosia SV, Bhalla K, and Bai W. SIRT1 sumoylation regulates its dea-cetylase activity and cellular response to genotoxic stress. Nat Cell Biol 9: 1253-1262, 2007.
30. Zech B, Wilm M, van ER, and Brune B. Mass spectrometric analysis of nitric oxide-modified caspase-3. J Biol Chem 274: 20931-20936, 1999.